Abbott India declares unaudited Q1 FY27 results
Abbott India Limited announced its unaudited financial results for the quarter ended June 30, 2026. The results were approved by the Board of Directors at a meeting held on August 12, 2026. The company's financial statements were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) and comply with SEBI Listing Regulations. The financial results have undergone a limited review by the statutory auditors, Walker Chandiok & Co. LLP, with no qualifications noted. The company operates in a single segment, Pharmaceuticals.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Results approved by the Board of Directors.
- Limited review by statutory auditors completed.
- No qualifications in the auditor's review report.
- Company operates in a single 'Pharmaceuticals' segment.
Price Impact
More from ABBOTINDIA
Abbott India: Trading Window Closure for Q2 FY27 Results
Abbott India Q1 FY27: standalone PAT up 17% YoY on margin expansion, revenue growth muted at 4%
Abbott India Board Meeting on Aug 12 to Approve Unaudited Results